Medicare Enrolled
Dr. Tom Floyd, M.D.
Urology Physician · Concord, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Floyd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Floyd?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Floyd
Dr. Tom Floyd is an urology physician in Concord, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Floyd performed 1,348 Medicare services across 997 unique beneficiaries.
Between the years covered by Open Payments, Dr. Floyd received a total of $11,063 from 59 pharmaceutical and/or device companies across 511 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Floyd is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 49% volume in NC
$11,063 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,348
Medicare services
Top 49% in NC for urology physician
997
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $86 | $158 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
245 | $3 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
232 | $60 | $110 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
101 | $8 | $45 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $136 | $786 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
73 | $165 | $585 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
52 | $0 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $101 | $263 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
38 | $59 | $185 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
18 | $100 | $295 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $43 | $73 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $316 | $1,850 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
15 | $152 | $626 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
15 | $19 | $264 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
15 | $20 | $87 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $243 | $826 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $138 | $231 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
16.0% medium
81.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,063
Total received (2018-2024)
Avg $1,580/year across 7 years
Top 15% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
511
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,063 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,921
2023
$2,383
2022
$1,879
2021
$1,598
2020
$943
2019
$1,032
2018
$1,307
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UROGEN PHARMA, INC.
$337
Sumitomo Pharma America, Inc.
$328
Dendreon Pharmaceuticals LLC
$187
Myriad Genetic Laboratories, Inc.
$121
Endo USA, Inc.
$116
ACCORD HEALTHCARE, INC.
$108
Olympus America Inc.
$102
Laborie Medical Technologies Corp.
$90
Tolmar, Inc.
$70
ABBVIE INC.
$51
Boston Scientific Corporation
$51
Mission Pharmacal Company
$50
Davol Inc.
$48
ConvaTec Inc.
$44
AngioDynamics, Inc.
$42
Ferring Pharmaceuticals Inc.
$36
PFIZER INC.
$22
PROCEPT BioRobotics Corporation
$21
Medtronic, Inc.
$21
Endo Pharmaceuticals Inc.
$21
Axonics, Inc.
$19
C. R. Bard, Inc. & Subsidiaries
$19
Astellas Pharma US Inc
$16
Top 3 companies account for 44.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,208
Sumitomo Pharma America, Inc.
$849
Boston Scientific Corporation
$737
Endo Pharmaceuticals Inc.
$714
Medtronic, Inc.
$507
Dendreon Pharmaceuticals LLC
$454
Coloplast Corp
$451
UROGEN PHARMA, INC.
$429
Antares Pharma, Inc.
$425
AbbVie, Inc.
$346
ACCORD HEALTHCARE, INC.
$345
UroGen Pharma, Inc.
$301
UROVANT SCIENCES INC
$277
Laborie Medical Technologies Corp.
$254
ABBVIE INC.
$251
BOSTON SCIENTIFIC CORPORATION
$247
PFIZER INC.
$246
Myovant Sciences Inc.
$243
TOLMAR Pharmaceuticals, Inc.
$211
Tolmar, Inc.
$194
Mission Pharmacal Company
$164
PROCEPT BioRobotics Corporation
$149
NeoTract Inc.
$138
Olympus America Inc.
$137
Rochester Medical Corporation
$135
Avadel Specialty Pharmaceuticals, LLC
$134
Myriad Genetic Laboratories, Inc.
$121
Endo USA, Inc.
$116
AbbVie Inc.
$105
Axonics, Inc.
$96
ConvaTec Inc.
$85
Merck Sharp & Dohme LLC
$82
Aytu BioScience, Inc
$82
Ferring Pharmaceuticals Inc.
$75
Amgen Inc.
$58
Kowa Pharmaceuticals America, Inc.
$56
Acerus Pharmaceuticals Corporation
$51
Davol Inc.
$48
Bayer HealthCare Pharmaceuticals Inc.
$47
AngioDynamics, Inc.
$42
Aytu Bioscience, Inc
$42
Merck Sharp & Dohme Corporation
$40
Progenics Pharmaceuticals, Inc.
$36
C. R. Bard, Inc. & Subsidiaries
$36
AstraZeneca Pharmaceuticals LP
$36
Foundation Medicine, Inc.
$36
Photocure Inc
$27
Medtronic USA, Inc.
$25
COLOPLAST CORP
$24
Blue Earth Diagnostics Limited
$22
Clarus Therapeutics Inc.
$21
Teleflex LLC
$16
Hollister Incorporated
$16
Janssen Biotech, Inc.
$15
Allergan, Inc.
$15
Retrophin, Inc.
$14
SRS Medical Systems, Inc.
$12
Allergan Inc.
$11
Egalet US Inc
$11
Top 3 companies account for 25.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ADVANCE · AMS · AMS 700 · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AdVance XP · Androgel · Axonics · Axumin · BARDIA · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CONTINENCE CARE · CURE CATHETER · Cysview · EDEX · ELIGARD · ERLEADA · FIRMAGON · FOUNDATIONONE HEME · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · GREENLIGHT · INTERSTIM · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUBRICATH · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PROLARIS · PROVENGE · PYLARIFY · Phasix Mesh · Prolia · Rezum Generator · SEGLENTIS · SPEEDICATH · SPRIX · Seglentis · SpaceOAR VUE System - 10mL · SpeediCath · TACTRA · TITAN · TOVIAZ · TRIA · Titan · URIBEL · URIBEL TABS · UROLIFT · Uribel · UroCuff · UroLift · Urocit-K · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
59
Per 100K population
25.5
County median income
$86,084
Nearest hospital
CAROLINAS MEDICAL CENTER-NORTHEAST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Floyd is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of NC peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Floyd experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Floyd performed 358 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Floyd receive payments from pharmaceutical companies?
Yes. Dr. Floyd received a total of $11,063 from 59 companies across 511 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Floyd's costs compare to other urology physicians in Concord?
Dr. Floyd's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Floyd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Concord
Browse urology physicians in Concord ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology